Last reviewed · How we verify
fentanyl- ketorolac
At a glance
| Generic name | fentanyl- ketorolac |
|---|---|
| Sponsor | Mansoura University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy (PHASE4)
- Comparing Intramuscular Fentanyl and Ketorolac With Nerve of Arnold (NOA) Block for Bilateral Myringotomy (PHASE4)
- Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries (NA)
- Dual-chamber Patient-controlled Analgesia for Postoperative Recovery (NA)
- Comparison of Inflammatory Factors, Pain Scale, and Postoperative Recovery Quality (QOR - 15) in Patients Undergoing Colorectal Cancer Surgery with Conventional General Anesthesia Techniques Compared to General Anesthesia Combined with Epidural Anesthesia At Prof. Ngoerah Hospital (PHASE4)
- Opioid-Free Anesthetic for Tonsillectomy (PHASE4)
- Does Type of Anesthesia Influence Inflammation Change After Breast Surgery? (NA)
- Opioid Free Anesthesia for Laparoscopic Cholecystectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fentanyl- ketorolac CI brief — competitive landscape report
- fentanyl- ketorolac updates RSS · CI watch RSS
- Mansoura University portfolio CI